Our ambition : regenerate and cure
A multidisciplinary team that pools its skills to pave the way for success.
Management team
Matthieu DE KALBERMATTEN
CEO
20 years of experience in executive management, corporate strategy, business development and sales, for medtech company and large multinationals.
Ibon
GARITAONANDIA
CSO
15 years of experience in stem cell research and regenerative medicine, including Translational Research at a Californian clinical stage biotechnology company developing stem cell-based therapies
Didier
HAGUENAUER
CMO / DSO
Didier has more than 30 years of extensive international experience in clinical development, clinical research and medical affairs from various companies, including AstraZeneca and Biotechs involved in cell therapy. Didier graduated as a Medical Doctor from the University of Paris and holds a Business Administration degree from ESSEC France.
Olivier
FRIEDRICH
CFO
15 years of experience in corporate finance, internal control, accounting and tax matters. Senior Manager at EY leading legal financial audits as well as due diligence transactions. CFO of a listed company on Euronext
Jean-Olivier
HIRSCH
COO
15 years of experience in the pharmaceutical industry, as director of pharmaceutical affairs, head of quality management and qualified person.
An optimal mix between successful entrepreneurs and Pharma experts:
Board of Directors
Jerome
KOCH
President of the board
Shareholder of CellProthera
- Co-founder of Cellprothera and shareholders.
- Chairman and CEO of Zuber-Laederich, a family-owned company that manages industrial and financial assets and has been active for 25 years as a developer of industrial sites undergoing conversion in France.
- Chairman of Dollfus et Muller, a manufacturer of conveyor belts and technical felts for the textile and tanning industries since 1811.
- Tuffier Ravier PY, Trader in Paris and Luxemburg.
Philippe
HENON
Board member
Shareholder of CellProthera
- Founder of Cellprothera.
- MD – Former Head of the Hematology Department – Mulhouse Hospital.
- Légion of Honor award.
Henri
ASSAF
Board member
Shareholder of CellProthera
- Co-founder of SAB, a publisher of banking software and managing director for 30 years.
- Director of Business Angel Paris, Investor in >15 start-ups
François
ANGER
Board member
Shareholder of CellProthera
- Chairman and co-founder of Addmedica (sold to Merieux)
- CFO of OTL Pharma
- Director of Economic Affairs, Pfizer
Elsy
BOGLIOLI
Independent board member
- Executive VP and COO of Cellectis
- Ind. Director at TreeFrog, GenSight Biologics, Metafora Biosystems, Inpart, FTI Consulting.
- BCG Partner and managing director.
Jean-Pascal
TRANIE
Independent board member
- Founder of Aloe PE Investment fund.
- Co-founder of PepKon (peptides).
- Board member Allogenica, Polygon.
- CEO Numericable
Steven
HILDEMANN
Independent board member
- EVP and CMO at Ipsen.
- Adjunct professor of medicine, university of Freiburg
- Board certified in cardiology.
CellProthera relies on the expertise of international key opinion leaders for its development, among which the members of EXCELLENT Trial Steering Committee *
Scientific Advisory Board
Prof. Deepak BHATT*
- Director of the Mount Sinai Fuster Heart Hospital Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY - USA
Prof. Cesario BORLOGAN
- Vice-Chairman of Research USF Morsani College of Medicine
- Director of Center of Excellence for Aging and Brain Repair, USF Health, Tampa FL - USA
Prof. Javed BUTLER
- President of the Baylor Scott and White Research Institute
- Distinguished Professor of Medicine at University of Mississipi in Jackson, MS - USA
Prof. Timothy HENRY
- Medical Director, The Carl and Edyth Lindner Center for Research and Education
- The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, OH - USA
Prof. Jeanne LORING
- Director of the Center for Regenerative Medicine, The Scripps Research Institute, La Jolla, CA - USA
- Founder of Aspen Neuroscience
Prof. Cesario BORLOGAN
- Vice-Chairman of Research USF Morsani College of Medicine
- Director of Center of Excellence for Aging and Brain Repair, USF Health, Tampa FL - USA
Prof. Gilles MONTALESCOT*
- Head of the Department of Cardiology at the Institute of Cardiology
- Hôpital de la Pitié-Salpétrière, Paris - France
Prof.Guilio POMPILIO
- Professor at the Department of Biomedical, Surgical, and Dental Sciences, University degli Studi di Milano
- Monzino Cardiology Center, University Hospital Milano - Italy
Prof. Jérôme RONCALLI*
- Director of the Heart Failure Unit in the Department of Cardiology at the University Hospital of Toulouse - France.
- Vice-President of the French Federation of Cardiology
Prof. Denis-Claude ROY
- Director of the Centre of Excellence for Cellular Therapy
- Founder and Executive Director of CellCAN University of Montreal Montreal - Canada
Prof. Scott SOLOMON*
- Distinguished Chair, Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital
- Director, Clinical Trials Outcomes Center, Harvard Medical School, Boston, MA - USA
Prof.Faïez ZANNAD*
- Emeritus Professor of Therapeutics at the University of Lorraine - France
- University of Lorraine, INSERM, CHRU Nancy, Multidisciplinary Clinical Investigation Center (CIC-P 1433)
Founders
In 2002, a successful Proof of Concept clinical study led by Prof. Philippe HENON – Founder and Director of IRHT Mulhouse – showing structural and functional regeneration of myocardial tissue as well as reperfusion of an infarcted zone after a recent Acute Myocardial Infarct (AMI) was performed and included 7 myocardial infarction patients with a very poor short-term prognosis. Based on the objective of building a robust and automated bioprocessing technology aimed at producing large numbers of purified stem cells, Philippe HENON and Jean-Claude JELSCH founded CellProthera in 2008.
Prof. Philippe HENON
At the origin of the therapeutic solution, Prof. Philippe HENON, MD – Head of the Hematology Department - Mulhouse Hospitals, is one of the pioneers in the field of peripheral blood stem cell (PBSC) identification and transplantation and performed the 6th peripheral blood stem cell transplantation in the world in 1986
He is member of twelve national and international scientific societies and corresponding member of the New York Academy of Sciences. As the founder of the “Institut de Recherche en Hématologie et Transplantation” (IRHT) in Mulhouse, he led a research program on stemcells and discovered that CD34+ cells could regenerate the heart after a severe myocardial infarct.
He is now member of the Board of Directors and Scientific Advisor.
Jean-Claude JELSCH